-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test is an affordable, accessible blood test that detects cancer in dogs.
Nu.Q® Discover Webinar:
Beyond the Genome: Measuring Epigenetic Modifications Across Matrices for Biomarker and Drug Discovery
Unlock the Power of Epigenetics in Cancer Research
Join our free webinar to explore how histone modifications are shaping the future of biomarker discovery and therapeutic development.
What you’ll learn:
✔️ How epigenetic profiling reveals novel drug targets
✔️ Case studies on EZH2/EED inhibitors in cancer immunoediting
✔️ Simple, robust Nu.Q® assays for translational research
Speakers:
🎤 Dr. Eric Ariazi – Translational Cancer Biologist
🎤 Marielle Herzog – R&D Director, Belgian Volition
Register for event
Join us to discover how the Nu.Q® Discover can aid your epigenetic drug development journey – register now to secure your place.